These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21400962)

  • 1. Glypican-3 immunostaining significantly improves histological diagnosis of hepatocellular carcinoma.
    Honsová E; Lodererová A; Franková S; Oliverius M; Trunecka P
    Cas Lek Cesk; 2011; 150(1):37-40. PubMed ID: 21400962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.
    Anatelli F; Chuang ST; Yang XJ; Wang HL
    Am J Clin Pathol; 2008 Aug; 130(2):219-23. PubMed ID: 18628090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
    Wang FH; Yip YC; Zhang M; Vong HT; Chan KI; Wai KC; Wen JM
    J Clin Pathol; 2010 Jul; 63(7):599-603. PubMed ID: 20501450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study.
    Zhang L; Liu H; Sun L; Li N; Ding H; Zheng J
    Acta Histochem; 2012 Oct; 114(6):547-52. PubMed ID: 22119409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.
    Sakamoto M; Mori T; Masugi Y; Effendi K; Rie I; Du W
    Intervirology; 2008; 51 Suppl 1():42-5. PubMed ID: 18544947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
    Longerich T; Haller MT; Mogler C; Aulmann S; Lohmann V; Schirmacher P; Brand K
    Pathol Res Pract; 2011 Jan; 207(1):8-14. PubMed ID: 20971570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
    Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
    Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
    Wang XY; Degos F; Dubois S; Tessiore S; Allegretta M; Guttmann RD; Jothy S; Belghiti J; Bedossa P; Paradis V
    Hum Pathol; 2006 Nov; 37(11):1435-41. PubMed ID: 16949914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma.
    Yorita K; Takahashi N; Takai H; Kato A; Suzuki M; Ishiguro T; Ohtomo T; Nagaike K; Kondo K; Chijiiwa K; Kataoka H
    Liver Int; 2011 Jan; 31(1):120-31. PubMed ID: 20964802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis.
    Yu J; Ma Q; Zhang B; Ma R; Xu X; Li M; Xu W; Li M
    Sci China Life Sci; 2013 Mar; 56(3):234-9. PubMed ID: 23526389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
    Saleh HA; Aulicino M; Zaidi SY; Khan AZ; Masood S
    Diagn Cytopathol; 2009 Mar; 37(3):184-90. PubMed ID: 19170172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
    Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
    Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.
    Roskams T; Kojiro M
    Semin Liver Dis; 2010 Feb; 30(1):17-25. PubMed ID: 20175030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Zou ZQ; Ding YP; Long B; Yuh JG; Xu AL; Lang ZW; Zou SY; Liu YD; Ding K; Li YY
    Hepatogastroenterology; 2010; 57(102-103):1285-90. PubMed ID: 21410073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genomic analysis of hepatocellular carcinoma and its application to diagnosis].
    Murakami Y
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():458-61. PubMed ID: 20979296
    [No Abstract]   [Full Text] [Related]  

  • 20. Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma.
    Abdul-Al HM; Makhlouf HR; Wang G; Goodman ZD
    Hum Pathol; 2008 Feb; 39(2):209-12. PubMed ID: 17949778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.